High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group
| Publication | Article in British Journal of Cancer, published December 1998 |
|---|---|
| Authors | OS Nielsen, P Dombernowsky, H Mouridsen, D Crowther, J Verweij, J Buesa, W Steward, S Daugaard, M...[ show more ] |
This is the public page for a publication record in Dimensions, a free research insights platform that brings together information about funding, scholarly outputs, policy, patents and grants.
Loading metrics…